Skip to main content
. 2015 Jul 12;3(1):59–67. doi: 10.1093/nop/npv023

Fig. 4.

Fig. 4.

A pseudoprogression case after chemoradiotherapy. An axial, Gd-contrast-enhanced T1-weighted image before chemoradiotherapy (A); 4 and 12 weeks after radiotherapy and concomitant temozolomide showing increased enhancement (B and C), raising the possibility of progressive disease; after additional 18, 28, 43, 50, 64 weeks of treatment (D–H) with adjuvant temozolomide after radiotherapy, showing a steady decrease in the Gd-enhancing lesion –typical pseudoprogression.